Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 16 Feb 2021 |
2 | Reply to Exam Report (MIS-R) | 04 Mar 2021 |
3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 20 Dec 2022 |
4 | Journal Copy | 15 Feb 2023 |
5 | Journal Copy | 15 Feb 2023 |
6 | TM-O(NOTICE OF OPPOSITION) | 07 Apr 2023 |
7 | TM-O(NOTICE OF OPPOSITION) | 14 Apr 2023 |
1 | Hearing Notice (Show Cause) | 14288454 | 02 Nov 2022 | |
2 | Tribunal Accepted Notice for : 4864803 | 14519409 | 5803857 | 21 Dec 2022 |
3 | Opposition Notice | 15388841 | 5996233 | 08 Jun 2023 |
4 | Opposition Notice | 16177088 | 6245945 | 04 Oct 2023 |
5 | Order Form of 21(2) | 16752270 | 6375773 | 07 Dec 2023 |
6 | Order Form of 21(2) | 16752272 | 6375748 | 07 Dec 2023 |
The application for Emdiace was made on 16 February 2021.
The trademark applicant for Emdiace is BLISS GVS PHARMA.
Emdiace is applied in class(es) 5.
Application for Emdiace is on Abandoned stage.
Application Id allotted to Emdiace is 4864803.
Trademark agent or attorney for the application is Innovative Consultants.
Emdiace filed with the Intellectual property office as a WORD.